{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:50:23Z","timestamp":1784328623253,"version":"3.55.0"},"reference-count":40,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"unspecified","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202211310"],"award-info":[{"award-number":["tsqn202211310"]}],"id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Natural Science Foundation of Shandong Province","award":["ZR2020MH035"],"award-info":[{"award-number":["ZR2020MH035"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070388"],"award-info":[{"award-number":["82070388"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170442"],"award-info":[{"award-number":["82170442"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,11,6]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Whether the glucose-insulin-potassium (GIK) should be used as an adjuvant therapy for ischaemic myocardial disease remains controversial nowadays reperfusion era. This meta-analysis aimed to assess the effects of preinitiated GIK for patients undergoing planned percutaneous coronary intervention (PCI).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Systematic review and meta-analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Data sources<\/jats:title>\n                  <jats:p>PubMed, Web of science, MEDLINE, Embase, Cochrane Library and ClinicalTrials.gov were searched through 27 November 2022.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Eligibility criteria<\/jats:title>\n                  <jats:p>Only randomised controlled trials involving participants preinitiated with GIK or placebo before planned PCI were included.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Data extraction and synthesis<\/jats:title>\n                  <jats:p>Two independent reviewers used standardised methods to search, screen and code included trials. Risk of bias was assessed with the Cochrane tool. Pooled analysis was conducted using random or effects models according to the heterogeneity. Subgroup analyses were carried out for dosage of GIK and if with ongoing myocardial ischaemia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>13 randomised controlled trials (RCTs) including 3754 participants were evaluated. We found patients preconditioned with GIK before PCI showed a significant increase in Thrombolysis in Myocardial Infarction 3 flow events after angioplasty (OR 1.59, 95% CI 1.03 to 2.46, p=0.04), also revealed improved in-hospital left ventricular ejection fraction (weighed mean difference, WMD 1.62, 95% CI 0.21 to 3.03, p=0.02) and myocardial salvage index (WMD 0.09, 95% CI 0.01 to 0.16, p=0.03). Nevertheless, no benefit was observed in all-cause mortality neither on 30-day (OR 0.81, 95% CI 0.59 to 1.11, p=0.18) nor 6\u2009months (OR 1.02, 95% CI 0.42 to 2.46, p=0.97). Furthermore, GIK intervention was associated with higher occurrences of complications such as phlebitis (OR 10.13, 95% CI 1.74 to 59.00, p=0.01) and hypoglycaemia (OR 10.43, 95% CI 1.32 to 82.29, p=0.03), but not hyperkalaemia (OR 9.36, 95% CI 0.50 to 175.27, p=0.13), liquid overload (OR 1.02, 95% CI 0.25 to 4.13, p=0.98) or in-hospital heart failure (OR 0.42, 95% CI 0.06 to 2.96, p=0.39).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our study shows preconditioning GIK exhibits myocardial reperfusion and cardiac function benefits for patients planning to receive PCI intervention, while also some complications such as phlebitis and hypoglycaemia accompany.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PROSPERO registration number<\/jats:title>\n                  <jats:p>CRD42022326334.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-073557","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T19:16:05Z","timestamp":1701976565000},"page":"e073557","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of preinitiated glucose-insulin-potassium strategy for patients with undergoing planned percutaneous coronary intervention: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"13","author":[{"given":"Huiruo","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine and Chest Pain Centre, Qilu Hospital of Shandong University, Jinan, Shandong, China"},{"name":"Key Laboratory of Emergency and Critical Care Medicine of Shandong Province, Qilu Hospital of Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rugang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine and Chest Pain Centre, Qilu Hospital of Shandong University, Jinan, Shandong, China"},{"name":"Key Laboratory of Emergency and Critical Care Medicine of Shandong Province, Qilu Hospital of Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine and Chest Pain Centre, Qilu Hospital of Shandong University, Jinan, Shandong, China"},{"name":"Key Laboratory of Emergency and Critical Care Medicine of Shandong Province, Qilu Hospital of Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4670-3727","authenticated-orcid":false,"given":"Feng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine and Chest Pain Centre, Qilu Hospital of Shandong University, Jinan, Shandong, China"},{"name":"Key Laboratory of Emergency and Critical Care Medicine of Shandong Province, Qilu Hospital of Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1224-0509","authenticated-orcid":false,"given":"Chuanbao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine and Chest Pain Centre, Qilu Hospital of Shandong University, Jinan, Shandong, China"},{"name":"Key Laboratory of Emergency and Critical Care Medicine of Shandong Province, Qilu Hospital of Shandong University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,12,7]]},"reference":[{"key":"2025101812380133000_13.12.e073557.1","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.121.011408","article-title":"Comparison of intracoronary epinephrine and adenosine for no-reflow in normotensive patients with acute coronary syndrome (COAR trial)","volume":"15","author":"Khan","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"2025101812380133000_13.12.e073557.2","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026232","article-title":"Effects of nicorandil administration on infarct size in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"11","author":"Qian","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2025101812380133000_13.12.e073557.3","doi-asserted-by":"publisher","DOI":"10.1177\/1089253211436350"},{"key":"2025101812380133000_13.12.e073557.4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000168928","article-title":"Acute myocardial infarction treated by glucose-insulin-potassium (GIK) infusion","volume":"49","author":"Sievers","year":"1966","journal-title":"Cardiologia (Basel)"},{"key":"2025101812380133000_13.12.e073557.5","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(80)90669-9"},{"key":"2025101812380133000_13.12.e073557.6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/bjs.1800730418","article-title":"Metabolic changes in the non-insulin-dependent diabetic undergoing minor surgery: effect of glucose-insulin-potassium infusion","volume":"73","author":"Thompson","year":"1986","journal-title":"Br J Surg"},{"key":"2025101812380133000_13.12.e073557.7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000170632","article-title":"Effects of glucose-insulin-potassium infusion on the angina response during treadmill exercise","volume":"64","author":"Thadani","year":"1979","journal-title":"Cardiology"},{"key":"2025101812380133000_13.12.e073557.8","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(87)90306-1"},{"key":"2025101812380133000_13.12.e073557.9","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(81)90406-3"},{"key":"2025101812380133000_13.12.e073557.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.09.086"},{"key":"2025101812380133000_13.12.e073557.11","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2261-14-169","article-title":"Glucose-insulin-potassium therapy in patients with acute coronary syndrome: a meta-analysis of randomized controlled trials","volume":"14","author":"Jin","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"key":"2025101812380133000_13.12.e073557.12","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2010.194563"},{"key":"2025101812380133000_13.12.e073557.13","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivv222"},{"key":"2025101812380133000_13.12.e073557.14","first-page":"262","article-title":"Preconditioning with glucose-insulin-potassium solution and restoration of myocardial function during coronary surgery","volume":"28 Spec No","author":"Jovic","year":"2009","journal-title":"Gen Physiol Biophys"},{"key":"2025101812380133000_13.12.e073557.15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and Exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025101812380133000_13.12.e073557.16","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(79)90081-X"},{"key":"2025101812380133000_13.12.e073557.17","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200202000-00025"},{"key":"2025101812380133000_13.12.e073557.18","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000079604.46997.7B"},{"key":"2025101812380133000_13.12.e073557.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.06.025"},{"key":"2025101812380133000_13.12.e073557.20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2004.01.019","article-title":"A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy","volume":"148","author":"Pache","year":"2004","journal-title":"Am Heart J"},{"key":"2025101812380133000_13.12.e073557.21","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.amjcard.2004.07.115","article-title":"Effect of glucose-insulin-potassium infusion on plasma free fatty acid concentrations in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction","volume":"94","author":"Addo","year":"2004","journal-title":"Am J Cardiol"},{"key":"2025101812380133000_13.12.e073557.22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.4.437"},{"key":"2025101812380133000_13.12.e073557.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.07.060"},{"key":"2025101812380133000_13.12.e073557.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.04.019"},{"key":"2025101812380133000_13.12.e073557.25","doi-asserted-by":"publisher","DOI":"10.3132\/dvdr.2007.043"},{"key":"2025101812380133000_13.12.e073557.26","doi-asserted-by":"publisher","DOI":"10.1097\/MCA.0b013e3282f27c34"},{"key":"2025101812380133000_13.12.e073557.27","unstructured":"Guoliang D . The effect of strengthen glucose-insulin-Kalium on myocardial reperfusion and inflammatory factors in patients with acute myocardial infarction after percutaneous coronary intervention. Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease 2019."},{"key":"2025101812380133000_13.12.e073557.28","first-page":"554","article-title":"Effects and mechanisms of glucose-insulin-potassium on post-procedural myocardial injury after percutaneous coronary intervention","volume":"17","author":"Hao","year":"2020","journal-title":"J Geriatr Cardiol"},{"key":"2025101812380133000_13.12.e073557.29","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-3-9","article-title":"The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction","volume":"3","author":"van der Horst","year":"2005","journal-title":"BMC Med"},{"key":"2025101812380133000_13.12.e073557.30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/eurheartj\/ehy504","article-title":"Anti-Anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment","volume":"40","author":"Ferrari","year":"2019","journal-title":"Eur Heart J"},{"key":"2025101812380133000_13.12.e073557.31","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1093\/eurheartj\/ehy529","article-title":"Systemic Microvascular dysfunction in Microvascular and Vasospastic angina","volume":"39","author":"Ford","year":"2018","journal-title":"Eur Heart J"},{"key":"2025101812380133000_13.12.e073557.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.03.054"},{"key":"2025101812380133000_13.12.e073557.33","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrneph.2016.145","article-title":"The impact of insulin resistance on the kidney and vasculature","volume":"12","author":"Artunc","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"2025101812380133000_13.12.e073557.34","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105039","article-title":"Searching for novel hydrogen sulfide donors: the vascular effects of two Thiourea derivatives","volume":"159","author":"Citi","year":"2020","journal-title":"Pharmacol Res"},{"key":"2025101812380133000_13.12.e073557.35","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1093\/eurheartj\/ehx414","article-title":"Relationship between Microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials","volume":"38","author":"de Waha","year":"2017","journal-title":"Eur Heart J"},{"key":"2025101812380133000_13.12.e073557.36","doi-asserted-by":"crossref","unstructured":"Hagerman A , Schorer R , Putzu A , et al . Cardioprotective effects of glucose-insulin-potassium infusion in patients undergoing cardiac surgery: A systematic review and meta-analysis. Semin Thorac Cardiovasc Surg 2022. doi:10.1053\/j.semtcvs.2022.11.002","DOI":"10.1053\/j.semtcvs.2022.11.002"},{"key":"2025101812380133000_13.12.e073557.37","doi-asserted-by":"crossref","unstructured":"Fu F , Zhao K , Li J , et al . n.d. Direct evidence that myocardial insulin resistance following myocardial ischemia contributes to post-ischemic heart failure. Sci Rep;5:17927. doi:10.1038\/srep17927","DOI":"10.1038\/srep17927"},{"key":"2025101812380133000_13.12.e073557.38","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw0638","article-title":"Apoptosis of hematopoietic progenitor-derived Adipose tissue-resident Macrophages contributes to insulin resistance after myocardial infarction","volume":"12","author":"Vasamsetti","year":"2020","journal-title":"Sci Transl Med"},{"key":"2025101812380133000_13.12.e073557.39","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A300"},{"key":"2025101812380133000_13.12.e073557.40","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.4.1152"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-073557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T19:38:14Z","timestamp":1760816294000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-073557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12,7]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/bmjopen-2023-073557"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-073557","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}